Antifibrinolytic
Antifibrinolytics are a class of medications that work by inhibiting the fibrinolytic system, thereby promoting blood clot formation and reducing excessive bleeding. These drugs are used in various medical settings, including surgery, trauma, and bleeding disorders. The most commonly used antifibrinolytic agents are tranexamic acid (TXA) and epsilon-aminocaproic acid (EACA).
Mechanism of Action
Antifibrinolytic agents work by inhibiting plasminogen activation and plasmin activity, which are essential components of the fibrinolytic system. The fibrinolytic system is responsible for breaking down blood clots by converting plasminogen to plasmin, which then degrades fibrin, the main component of blood clots. By inhibiting this process, antifibrinolytic agents help maintain blood clot stability and prevent excessive bleeding.
Clinical Applications
Antifibrinolytic agents have a variety of clinical uses, primarily in the prevention and treatment of excessive bleeding.
Surgery
Antifibrinolytic agents are commonly used in surgeries with a high risk of blood loss, such as cardiac, orthopedic, and liver surgeries. These drugs can help reduce the need for blood transfusions and decrease postoperative bleeding complications. They are administered before, during, or after the surgery, depending on the specific situation and the surgeon's preference.
Trauma
In cases of severe trauma or injury, antifibrinolytic agents may be administered to reduce bleeding and improve patient outcomes. The CRASH-2 trial, a large-scale study published in 2010, demonstrated that early administration of tranexamic acid in trauma patients significantly reduced the risk of death due to bleeding.
Bleeding Disorders
Antifibrinolytic agents can also be used to manage bleeding in patients with certain bleeding disorders, such as von Willebrand disease and hemophilia. They may be prescribed as part of a prophylactic regimen or as an on-demand treatment for acute bleeding episodes.
Side Effects and Contraindications
While antifibrinolytic agents are generally well-tolerated, they may cause side effects in some patients. Common side effects include:
Serious side effects, although rare, include:
- Seizures
- Thromboembolic events, such as deep vein thrombosis or pulmonary embolism
- Acute renal failure
Antifibrinolytic agents are contraindicated in patients with a history of thromboembolic events or those at high risk for developing blood clots. Additionally, they should be used with caution in patients with renal impairment or a history of seizures.
Future Research
Ongoing research aims to further refine the use of antifibrinolytic agents and to identify novel therapeutic targets in the fibrinolytic pathway. For example, studies are investigating the optimal dosing and timing of antifibrinolytic administration in various clinical scenarios, as well as the potential role of these agents in managing obstetric hemorrhage.
Pharmacology
Fibrinolytic drugs are given after a heart attack to dissolve the thrombus blocking the coronary artery, experimentally in stroke to reperfuse the affected part of the brain, and in massive pulmonary embolism. The process is called thrombolysis.
Antifibrinolytics, such as aminocaproic acid (ε-aminocaproic acid) and tranexamic acid are used as inhibitors of fibrinolysis, which act by blocking the lysine-binding site on plasmin. They are used in menorrhagia and bleeding tendency due to various causes.
References
- Cesarman-Maus G, Hajjar KA. Molecular mechanisms of fibrinolysis. Br J Haematol 2005;129:307-21. PMID 15842654.
- Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., Copyright © 2005 Saunders
- Walker JB, Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem. 1999;274:5201 - 5212. PMID 9988770.
External link
- Graphical representation of the fibrinolytic pathway
This article is a medical stub. You can help WikiMD by expanding it! | |
---|---|
Major chemical drug groups | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Antihemorrhagics (B02) | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD